ACE2 and COVID-19: This absence of COVID-19 from our patient cohort was shown to be significant when statistically compared to the adjusted prevalence of COVID-19 in the general northern Italian population (7), suggesting that increased ACE2 and reduced ROCK activity likely provide benefits in terms of reduced risk of COVID-19, such as those we found in GS/BS.